0000880771-17-000128.txt : 20170816 0000880771-17-000128.hdr.sgml : 20170816 20170816200509 ACCESSION NUMBER: 0000880771-17-000128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170815 FILED AS OF DATE: 20170816 DATE AS OF CHANGE: 20170816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xie Lan CENTRAL INDEX KEY: 0001555794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 171037508 MAIL ADDRESS: STREET 1: 29F SHANGHAI TIMES SQUARE STREET 2: NO. 93 HUAI HAI ZHONG ROAD CITY: SHANGHAI STATE: F4 ZIP: 200021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2017-08-15 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001555794 Xie Lan 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 VP Finance, China CFO Common Stock 2017-08-15 4 M 0 10000 0 A 10000 D Common Stock 2017-08-16 4 S 0 10000 11.00 D 0 D Restricted Stock Unit 2017-08-15 4 M 0 10000 0 D Common Stock 10000 8000 D Granted under the Issuer's 2015 Equity Incentive Plan. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017. /s/ Friedhelm Blobel, Attorney-in-Fact For: Lan Xie 2017-08-16